Latest return on equity
Clinuvel Pharmaceuticals Return on equity
Direct answer
Clinuvel Pharmaceuticals's return on equity is 13.21%.
The verified market snapshot reports 13.21%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 5, 2026.
Get free Clinuvel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 13.21%
Explore related company data
View Clinuvel Pharmaceuticals's market capitalizationView Clinuvel Pharmaceuticals's p/e ratioView Clinuvel Pharmaceuticals's price-to-book ratioView Clinuvel Pharmaceuticals's dividend yieldView Clinuvel Pharmaceuticals's 52-week price rangeView Clinuvel Pharmaceuticals's revenue growthView Clinuvel Pharmaceuticals's profit marginView Clinuvel Pharmaceuticals's debt-to-equity ratioView all Clinuvel Pharmaceuticals key metricsReturn to Clinuvel Pharmaceuticals profile